RAB Microfluidics
75 Beech Manor, Stoneywood, Aberdeen, Aberdeen City, AB21 9AZ, United Kingdom
Overview
RAB-Microfluids has developed and patented a microfluidic "lab on a chip" designed to diagnose early signs of lubrication-related equipment failure in real time. The device targets main engines, gearboxes and generators and the company says it can be up to 1,000 times faster and significantly cheaper than land-based laboratories. RAB-Microfluids intends to launch the device later this year and will showcase it at trade fairs starting at SMM in Hamburg. To scale production and obtain regulatory approvals it is moving to larger premises at Aberdeen’s Energy Development Centre and will kickstart manufacturing there. The funding will also support a strengthened corporate, sales and marketing operation and the creation of eight new roles. The company reports it is winning new business from pilot projects, including work with NorthLink Ferries, and is aiming to hit a £2m turnover by 2024. RAB-Microfluidics develops laboratory-on-a-chip technology that enables on-site analysis of oil samples from heavy machinery rather than shipping samples to onshore labs. The company says its approach delivers oil analysis more than 1,000 times faster and around 10 times cheaper than conventional laboratory testing. Founded in 2016 by Dr. Rotimi Alabi and built out of the University of Aberdeen, the firm participated in OGTC’s TechX Pioneers accelerator in 2018. Its customer base spans the UK and international markets across aerospace, defence, maritime, oil and gas, transport, processing and manufacturing industries. The company plans to use new investment to strengthen its team and advance its product roadmap. It recently secured fresh funding to support this next phase of commercialisation.
- Total raised
- $4M
- Funding rounds
- 2
- Latest round
- Equity
- Latest activity
- Aug 2022
Industries
- Aerospace
- Manufacturing
- Marine Transportation
- Nanotechnology
- Oil and Gas
- Renewable Energy
Recent funding
Equity
Aug 2022
$3M
Equity
Jan 2021
$2M